Induction of expression and activity of Glo1 with related change in target pharmacology provided the opportunity to explore the association by correlation analysis of glyoxalase system-linked variables with clinical characteristics of dysglycemia and insulin resistance, vascular inflammation, blood pressure, and dyslipidemia. This evidence concerns the gene GLO1 and Insulin resistance.